Survival analysis after stereotactic ablative radiotherapy for early stage non-small cell lung cancer: a single-institution cohort study

Stereotactic ablative radiotherapy (SABR) is the standard treatment for medically inoperable early-stage non-small cell lung cancer (ES-NSCLC), but which patients benefit from stereotactic radiotherapy is uncl...

Source: Radiation Oncology - April 18, 2024 Category: Cancer & Oncology Authors: Kamila Resova, Lukas Knybel, Tereza Parackova, Marian Rybar, Karel Cwiertka and Jakub Cvek Tags: Research Source Type: research